HT
AERI

HAP Trading’s Aerie Pharmaceuticals AERI Stock Holding History

HAP Trading’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-14,880
Closed -$902K – 1211
2017
Q3 		$723K Buy
+14,880
New +$812K 0.03% 303
2017
Q1 		– Sell
-11,848
Closed -$448K – 1325
2016
Q4 		$448K Buy
+11,848
New +$448K 0.02% 362
2015
Q4 		– Sell
-42,645
Closed -$757K – 1164
2015
Q3 		$757K Sell
42,645
-10,079
-19% -$183K 0.04% 306
2015
Q2 		$931K Buy
+52,724
New +$967K 0.06% 270

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HAP Trading's AERI Position: Q4 2017 in Review

HAP Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2017, closing a stake of 14,880 shares — an estimated $902K sold.

HAP Trading first reported a position in AERI in Q2 2015 and held it in 4 quarters. The position peaked at $931K in Q2 2015. 179 funds tracked by Wall St. Rank hold AERI as of Q4 2017.

  • HAP Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • HAP Trading sold 14,880 Aerie Pharmaceuticals shares in Q4 2017, an estimated $902K.
  • HAP Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • HAP Trading's Aerie Pharmaceuticals position peaked at $931K in Q2 2015.
  • 179 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2017.

Based on HAP Trading's 13F filing for Q4 2017, filed 9 Feb 2018.